Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:18 PM
Ignite Modification Date:
2026-03-26 @ 3:18 PM
NCT ID:
NCT07418567
Eligibility Criteria:
Inclusion Criteria:
* Age 18-64 years
* Diagnosis Long Covid based on WHO criteria (post-acute COVID-19 symptoms persisting ≥12 weeks) and validiated by an experienced cinician
* Normal body Mass Index (18.5 to 39 kg/m2)
* Able to communicate in and comprehend English and/or French language
* Present written / signed declaration of consent
* Ability to understand the patient information and willingness to sign the consent form
* Willing to limit physical activity during prolonged fasting
Exclusion Criteria:
* Current underweight condition (body mass index less than 18.5 kg/m2) or weight loss exceeding 3 kg within the last month or 5 kg within the last three months.
* Current or history of eating disorder (e.g., anorexia, bulimia).
* Psychiatric condition that limits understanding of the examination protocol (unable to consent)
* Participation in another intervention study.
* Fasting during the last six months
* Pregnancy or breastfeeding status.
* Diagnosis of chronic inflammatory bowel diseases, celiac disease or colorectal cancer according to the guidelines of the Canadian Society of Gastroenterology
* Use of anti-psychotic drugs
* Start of novel drug therapy for long COVID
* Contraindication for additional blood draws (e.g. hemoglobin \<100)
* Taking opioid analgesics or undergoing treatment for opioid addiction
* Opioid dependence or withdrawal syndrome
* Type 1 or 2 Diabetes, or history of hypoglycemia
* Active cancer
* Baseline E+ (Na, K, Mg, phosphate) within normal range
* Baseline ALT \< 60
* Baseline Hb \> 100
* Baseline INR within normal range
* Baseline DFG \< 50
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT07418567
Study Brief:
Protocol Section:
NCT07418567